Drugs repurposing against SARS-CoV2 and the new variant B.1.1.7 (alpha strain) targeting the spike protein: molecular docking and simulation studies
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) is responsible for the global COVID-19 pandemic and millions of deaths worldwide.In December 2020, a new alpha strain of SARS-CoV2 was identified in the United Kingdom.It was referred to as VUI 202012/01 (Alpha strain modelled under investigation, 2020, month 12, number 01).The interaction